Wenhong Shen

642 citations
10 papers · 416 indexed · 1 hit paper · h-index 4
Topics
Acute Myeloid Leukemia Research (2 papers)Bone and Joint Diseases (2 papers)Chronic Lymphocytic Leukemia Research (2 papers)
Partner nations
ChinaPakistanFiji

In The Last Decade

Wenhong Shen

9 papers receiving 412 citations

Hit Papers

Erratum: First-in-man clinical trial of CAR NK-92 cells: ...20182026202020232018100200300

Peers

Wenhong Shen
Comparison fields: 5 of 50
  • Oncology 332
  • Immunology 302
  • Hematology 83
  • Molecular Biology 80
  • Genetics 63
Replace Kevin M. Friedman with:
Kevin M. Friedman United States
Antonia Rotolo United States
Shreya Kant United States
Dirk Hönemann Australia
Tiina Hannunen Finland
Antonio Valeri Spain
Kirsten Nikolajsen Denmark
Jine Zheng China
Jessica Cantrell United States
Julia Riewaldt Germany
Wenhong Shen relative to Kevin M. Friedman United States Kevin M. Friedman's profile →
Citations per field
00.5×1.5×
Kevin M. Friedman · 1×
Citations per year

Countries citing papers authored by Wenhong Shen

Since Specialization
Citations

This map shows the geographic impact of Wenhong Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenhong Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenhong Shen more than expected).

Fields of papers citing papers by Wenhong Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenhong Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenhong Shen. The network helps show where Wenhong Shen may publish in the future.

Co-authorship network of co-authors of Wenhong Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Wenhong Shen. A scholar is included among the top collaborators of Wenhong Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenhong Shen. Wenhong Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 6
2 3
3 1
4 8
5
Erratum: First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia.breakdown →
356
6 37
7
[Detection of tissue factor-positive microparticles and its clinical significance in the haemostatic disorder].
0
8 2
9
[Influence of arsenic trioxide and daunorubicin on the expression of annexin II and fibrinolytic activity in NB4 cells].
2
10
[Clinical study on the fibrinolytic activity in patients with acute promyelocytic leukemia].
1

About Wenhong Shen

Wenhong Shen is a scholar working on Hematology, Genetics and Orthopedics and Sports Medicine, having authored 10 papers that have together received 416 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (2 papers), Bone and Joint Diseases (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Immunology (302 citations), Oncology (332 citations) and Hematology (83 citations). Wenhong Shen has collaborated with scholars based in China, Pakistan and Fiji. Frequent co-authors include Xiaowen Tang, Depei Wu, Mingqing Zhu, Lin Yang, Ting Xu, Jia Yin, Fengtao You, Haiping Dai, Guanghua Chen and Xiaming Zhu. Their work appears in journals such as Blood, ACS Omega and Molecular Carcinogenesis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026